Trial
NCT04039867
Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
—
Condition
Carcinoma, Transitional Cell
Intervention
Oxaliplatin with Gemcitabine
Why stopped
Trial was terminated due to halt in funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-21